Enlivex Therapeutics Investor Relations Material
Latest events
Company Presentation
3 Jun, 2025
Q4 2024
29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enlivex Therapeutics Ltd
Access all reports
Enlivex Therapeutics Ltd is an Israel-based clinical-stage biopharmaceutical company focused on developing allogeneic cell therapies for life-threatening immune-related diseases. The company’s lead investigational product is designed to modulate the immune system to restore immune balance in conditions such as sepsis, solid tumors, and other inflammatory disorders. Enlivex conducts clinical trials and research to advance its immunotherapy platform. The company is headquartered in Nes Ziona, Israel, and its shares are listed on the NASDAQ.
Key slides for Enlivex Therapeutics Ltd
Company Presentation
Enlivex Therapeutics Ltd
Company Presentation
Enlivex Therapeutics Ltd
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
ENLV
Country
🇮🇱 Israel